Even under prescription guidelines, drugs like Ozempic come ... in lengthy weight management programmes before a GLP-1 receptor agonist is even considered. Many are discouraged by the high price ...

Researchers had found in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 ...

UK: A recent consensus statement from leading UK medical organizations—including the Association of Anaesthetists, the ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

Find out if it's safe to drink alcohol during your Ozempic treatment, whether alcohol raises the risk of any sides effects, ...

Dr. Philip A. Chan joined GoLocal to discuss the new wave of weight loss drugs and their implications for fighting obesity as ...

With today’s sweetener market evolving rapidly, experts highlight how natural sweetener solutions are helping beverage-makers ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...